The device, called Vigilance', a computer-driven assembly of ultraviolet lights combined with other technologies, was developed by FP Technologies, Inc., in Buffalo.
Results of the study, conducted by University at Buffalo neonatologists in collaboration with company scientists, were presented today (May 3) at the Pediatric Academic Societies meeting being held May 3-5 in Seattle.
"This device significantly reduced microbial contamination in our neonatal intensive care unit, and spared our tiny patients from exposure to many infection-causing organisms," said Rita Ryan, M.D., UB associate professor of pediatrics and lead author on the study.
"It appears than ultraviolet germicidal irradiation may decrease the mortality and morbidity associated with hospital-acquired infections. This device should greatly improve the outcome of our premature infants by decreasing their risk of acquiring chronic lung disease and shortening their hospital stay."
Infections that patients contract while they are in the hospital are a major public-health concern. They cause unnecessary patient suffering and keep patients in the hospital longer, increasing health-care costs by an estimated $4.5 billion. To decrease the presence of microbes responsible for these infections, the Centers for Disease Control has recommended that hospitals install ultraviolet germicidal irradiation devices, such as the one used in this study, in their heating, ventilation and cooling systems.
The UB pediatricians undertook a study to determine if installing the device in the area's major neonatal intensive care unit w
Contact: Lois Baker
University at Buffalo